XML 165 R133.htm IDEA: XBRL DOCUMENT v3.6.0.2
Segment Reporting (Revenue by Product) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenue from External Customer [Line Items]      
Product sales $ 10,885.8 $ 6,099.9 $ 5,830.4
Hematology      
Revenue from External Customer [Line Items]      
Product sales 2,240.8 0.0 0.0
HEMOPHILIA      
Revenue from External Customer [Line Items]      
Product sales 1,789.0 0.0 0.0
INHIBITOR THERAPIES      
Revenue from External Customer [Line Items]      
Product sales 451.8 0.0 0.0
Genetic Diseases      
Revenue from External Customer [Line Items]      
Product sales 2,698.0 2,398.9 2,327.1
CINRYZE      
Revenue from External Customer [Line Items]      
Product sales 680.2 617.7 503.0
ELAPRASE      
Revenue from External Customer [Line Items]      
Product sales 589.0 552.6 592.8
FIRAZYR      
Revenue from External Customer [Line Items]      
Product sales 578.5 445.0 364.2
REPLAGAL      
Revenue from External Customer [Line Items]      
Product sales 452.4 441.2 500.4
VPRIV      
Revenue from External Customer [Line Items]      
Product sales 345.7 342.4 366.7
KALBITOR      
Revenue from External Customer [Line Items]      
Product sales 52.2 0.0 0.0
Neuroscience      
Revenue from External Customer [Line Items]      
Product sales 2,490.5 2,200.4 2,204.5
VYVANSE      
Revenue from External Customer [Line Items]      
Product sales 2,013.9 1,722.2 1,449.0
ADDERALL XR      
Revenue from External Customer [Line Items]      
Product sales 363.8 362.8 383.2
Other Neuroscience      
Revenue from External Customer [Line Items]      
Product sales 112.8 115.4 372.3
Immunology      
Revenue from External Customer [Line Items]      
Product sales 1,516.1 0.0 0.0
IMMUNOGLOBULIN THERAPIES      
Revenue from External Customer [Line Items]      
Product sales 1,143.9 0.0 0.0
BIO THERAPEUTICS      
Revenue from External Customer [Line Items]      
Product sales 372.2 0.0 0.0
Internal Medicine      
Revenue from External Customer [Line Items]      
Product sales 1,755.5 1,500.6 1,298.8
LIALDA/MEZAVANT      
Revenue from External Customer [Line Items]      
Product sales 792.1 684.4 633.8
PENTASA      
Revenue from External Customer [Line Items]      
Product sales 309.4 305.8 289.7
GATTEX/REVESTIVE      
Revenue from External Customer [Line Items]      
Product sales 219.4 141.7 0.0
NATPARA      
Revenue from External Customer [Line Items]      
Product sales 85.3 24.4 0.0
Other Internal Medicine      
Revenue from External Customer [Line Items]      
Product sales 349.3 344.3 375.3
Oncology      
Revenue from External Customer [Line Items]      
Product sales 130.5 0.0 0.0
Opthalmology      
Revenue from External Customer [Line Items]      
Product sales $ 54.4 $ 0.0 $ 0.0